Catalog: | C0630A |
Product Type: | Antibody |
Reactivity: | H,M |
Analysis mode: | IHC,ELISA |
Host: | Rabbit |
Clonality: | Polyclonal |
Isotype: | IgG |
Concentration: | 0.7 mg/mL |
Storage: | -20℃ |
Buffer: | PBS with 0.05% sodium azide and 50% glycerol, PH7.4 |
Purification method: | Affinity purification |
Application: | Cancer, Epigenetics and Nuclear Signaling |
Conjugation: | Unconjugated |
Immunogen: | RUNX1T1 |
Swiss port: | Q06455 |
Gene accession: | NP001185554 |
Celluar localization: | Nucleus |
Tissue specificity: | It is most expressed in the brain, but lower in the lungs, heart, testes and ovaries. |
This gene encodes a member of the myeloid translocation gene family that interacts with DNA-bound transcription factors and recruits a series of co-repressor factors to promote transcriptional inhibition. t(8;21)(q22;q22) translocation is one of the most common karyotypic abnormalities in acute myeloid leukemia. The translocation produces a chimeric gene, which is formed by fusing the 5'-region of the runt-related transcription factor 1 gene with the 3'-region of the gene. The chimeric protein is believed to bind to the nuclear co-inhibitor/histone deacetylase complex, thereby hindering hematopoietic differentiation.
Copyright © 2025 Creative Biogene. All rights reserved.